Alerts will be sent to your verified email
Verify Email
GUJINJEC
|
Guj. Inject (Kerala)
|
Biofil Chem & Pharma
|
Vista Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.55 % | 4.39 % | -9.01 % |
|
5yr average Equity Multiplier
|
0.11 | 2.06 | 1.42 |
|
5yr Average Asset Turnover Ratio
|
0.45 | 0.95 | 0.08 |
|
5yr Avg Net Profit Margin
|
-175.28 % | 2.38 % | -205.63 % |
|
Price to Book
|
5.02 | 2.53 | 1.21 |
|
P/E
|
119.78 | 18.79 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-14.62 Days | 75.63 Days | 124.89 Days |
|
Inventory Days
|
38.61 Days | 28.27 Days | 3040.44 Days |
|
Days Receivable
|
0.0 | 389.8 Days | 137.33 Days |
|
Days Payable
|
156.02 Days | 203.89 Days | 1845.08 Days |
|
5yr Average Interest Coverage Ratio
|
298.1 | 23.53 | -2.88 |
|
5yr Avg ROCE
|
2.0 % | 6.37 % | -8.17 % |
|
5yr Avg Operating Profit Margin
|
-279.73 % | 3.78 % | -192.46 % |
|
5 yr average Debt to Equity
|
-0.62 | 0.03 | 0.26 |
|
5yr CAGR Net Profit
|
n/a | -14.7 % | 19.73 % |
|
5yr Average Return on Assets
|
-116.01 % | 2.37 % | -6.49 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 46.79 % | 21.19 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.03 % | -14.25 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -0.02 % |
|
Guj. Inject (Kerala)
|
Biofil Chem & Pharma
|
Vista Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|